Prediction of Hypotension Using Perfusion Index Following Spinal Anesthesia in Lower Segment Caesarean Section

April 9, 2018 updated by: Achyut Sharma, Paropakar Maternity and Women's Hospital

Spinal anesthesia for caesarean section is invariably associated with variable degree of hypotension. Hypotension that occurs may be detrimental to various organ system due to inadequate perfusion. Various methods and agents have been tried in order to address this problem. However, this calamity is far from over.

Perfusion index is one such attempt to address the problem of hypotension by predicting which group of parturient may develop hypotension. This is a type of non-invasive method of assessing the relative vascular tone with the use of pulse oximeter which calculates the ration of pulsatile versus the non-pulsatile component of the blood flow. During normal physiological changes in pregnancy, there is relative loss of vascular tone which predisposes this group of patient to sudden development of hypotension after the sympathetic block due to spinal anesthesia.

Thus, the aim of the study is to use the non-invasive perfusion index data to predict the occurrence of hypotension in a parturient so that helps us to guide fluid and other drug therapy to address the problem of hypotension.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

130

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Parturient presenting to Paropakar Maternity and Women's Hospital for elective caesarean section.

Description

Inclusion Criteria:

  1. ASA II physical status.
  2. Planned for elective LSCS
  3. Gestational age >36 weeks and <41 weeks

Exclusion Criteria:

  1. Patient's refusal.
  2. Emergency LSCS.
  3. Patient's with contraindications to spinal anesthesia
  4. Patient with BMI >40, preeclampsia, placenta praevia.
  5. Patients with comorbidities like cerebrovascular or cardiovascular disease, and gestational diabetes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group I (Perfusion Index <3.5)
Those parturient with perfusion index <3.5 when baseline monitors are attached while the patient is being prepared for surgery.
Use of non-invasive pulse oximeter to determine perfusion index
Group II (Perfusion index >3.5)
Those parturient with perfusion index >3.5 when baseline monitors are attached while the patient is being prepared for surgery.
Use of non-invasive pulse oximeter to determine perfusion index

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of hypotension
Time Frame: 3 months
compare the incidence of hypotension following SAB for LSCS in parturient with or without a high perfusion index.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perfusion index
Time Frame: 3 months
To compare the perfusion index (PI) at various intervals between the two groups
3 months
Side-effects
Time Frame: 3 months
To study the profile of side effects between the two groups.
3 months
Systolic blood pressure
Time Frame: 3 months
To compare the systolic blood pressure (SBP) at various intervals between the two groups.
3 months
Diastolic blood pressure
Time Frame: 3 months
To compare the diastolic blood pressure (DBP) at various intervals between the two groups.
3 months
Mean arterial pressure
Time Frame: 3 months
To compare the mean arterial pressure (MAP) at various intervals between the two groups
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

May 1, 2018

Primary Completion (ANTICIPATED)

August 30, 2018

Study Completion (ANTICIPATED)

November 15, 2018

Study Registration Dates

First Submitted

October 19, 2017

First Submitted That Met QC Criteria

October 19, 2017

First Posted (ACTUAL)

October 24, 2017

Study Record Updates

Last Update Posted (ACTUAL)

April 11, 2018

Last Update Submitted That Met QC Criteria

April 9, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ParopakarMWH

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypotension

Clinical Trials on Perfusion Index

3
Subscribe